The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $43.50

Today's change+0.09 +0.21%
Updated July 26 1:36 PM EDT. Delayed by at least 15 minutes.
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $43.50

Today's change+0.09 +0.21%
Updated July 26 1:36 PM EDT. Delayed by at least 15 minutes.

Abbott Laboratories Hits New 50-day High

Abbott Laboratories is up today by (U.S.)$0.09 or 0.21% to (U.S.)$43.50 and setting a new 50-day high. Over the last five days, shares have gained 4.07%, but are down 3.14% for the last year to date. Shares have underperformed the S&P 500 by 18.82% during the last year.

Key company metrics

  • Open(U.S.) $43.39
  • Previous close(U.S.) $43.41
  • High(U.S.) $43.58
  • Low(U.S.) $43.36
  • Bid / Ask(U.S.) $43.49 / (U.S.) $43.50
  • YTD % change-3.14%
  • Volume4,946,787
  • Average volume (10-day)9,579,035
  • Average volume (1-month)10,231,313
  • Average volume (3-month)9,691,581
  • 52-week range(U.S.) $36.00 to (U.S.) $51.24
  • Beta1.03
  • Trailing P/E33.39×
  • P/E 1 year forward19.74×
  • Forward PEG2.12×
  • Indicated annual dividend(U.S.) $1.04
  • Dividend yield2.39%
  • Trailing EPS(U.S.) $1.30
Updated July 26 1:36 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue5,3334,8855,1885,150
Total other revenue--------
Total revenue5,3334,8855,1885,150
Gross profit3,0462,7462,9662,941
Total cost of revenue2,2872,1392,2222,209
Total operating expense4,5174,3614,3734,437
Selling / general / administrative1,7371,6831,6561,640
Research & development348379375338
Depreciation / amortization145144143151
Interest expense (income), net operating--------
Unusual expense (income)--16-2399
Other operating expenses, total--------
Operating income816524815713
Interest income (expense), net non-operating-83-58-41-41
Gain (loss) on sale of assets--------
Other--------
Income before tax7152830714
Income after tax59956695596
Income tax, total116-54135118
Net income615316767580
Total adjustments to net income--------
Net income before extra. items59956695596
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items59956695596
Inc. avail. to common incl. extra. items615316767580
Diluted net income615316767580
Dilution adjustment--0----
Diluted weighted average shares1,4801,4841,4971,505
Diluted EPS excluding extraordinary itemsvalue per share0.400.040.460.40
Dividends per sharevalue per share0.260.260.260.24
Diluted normalized EPSvalue per share0.400.040.450.45